The thrombotic potential of circulating tumor microemboli: Computational modeling of circulating tumor cell-induced coagulation

American Journal of Physiology - Cell Physiology

Volumn 308, Issue 3, 2015, Pages C229-C236

  Phillips, Kevin G ^a   Lee, Angela M ^b   Tormoen, Garth W ^a   Rigg, Rachel A ^a   Kolatkar, Anand ^c   Luttgen, Madelyn ^c   Bethel, Kelly ^d   Bazhenova, Lyudmila ^e   Kuhn, Peter ^c   Newton, Paul ^b   McCarty, Owen J T ^a,f  

^a Oregon Health and Science University Department of Biomedical Engineering   (United States)

^b University of Southern California   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d SCRIPPS CLINIC   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Advection diffusion equation; Circulating tumor microemboli; Coagulation; Lung cancer; Navier Stokes equation; Tissue factor; Venous thromboembolism

Indexed keywords

THROMBIN;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD FLOW; CASE REPORT; CELL SURFACE; CIRCULATING TUMOR CELL; CIRCULATING TUMOR MICROEMBOLISM; FEMALE; HUMAN; HUMAN CELL; MICROEMBOLISM; MIDDLE AGED; PRIORITY JOURNAL; SIMULATION; TUMOR MODEL; VENOUS THROMBOEMBOLISM; ADENOCARCINOMA; BIOLOGICAL MODEL; BLOOD; FOLLOW UP; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR EMBOLISM;

ADENOCARCINOMA; BLOOD COAGULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PATIENT-SPECIFIC MODELING; VENOUS THROMBOEMBOLISM;

EID: 84922212663     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00315.2014     Document Type: Article

References (26)

1. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10: 6897–6904, 2004
2. Berny-Lang MA, Aslan JE, Tormoen GW, Patel IA, Bock PE, Gruber A, McCarty OJ. Promotion of experimental thrombus formation by the procoagulant activity of breast cancer cells. Phys Biol 8: 015014, 2011
3. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293: 715–722, 2005
4. Bodner T, Sequeira A. Numerical simulation of the coagulation dynamics of blood. Comput Math Methods Med 9: 83–104, 2008
5. Cho EH, Wendel M, Luttgen M, Yoshioka C, Marrinucci D, Lazar D, Schram E, Nieva J, Bazhenova L, Morgan A, Ko AH, Korn WM, Kolatkar A, Bethel K, Kuhn P. Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Phys Biol 9: 016001, 2012
6. Damania D, Subramanian H, Backman V, Anderson EC, Wong MH, McCarty OJ, Phillips KG. Network signatures of nuclear and cytoplasmic density alterations in a model of pre and postmetastatic colorectal cancer. J Biomed Opt 19: 16016, 2014
7. Gomez K, McVey JH. Tissue factor initiated blood coagulation. Front Biosci 11: 1349–1359, 2006
8. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapyassociated thrombosis. Blood 111: 4902–4907, 2008
9. Lee AM, Tormoen GW, Kanso E, McCarty OJ, Newton PK. Modeling and simulation of procoagulant circulating tumor cells in flow. Front Oncol 2: 108, 2012
10. Marchetti M, Diani E, ten Cate H, Falanga A. Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography. Haematologica 97: 1173–1180, 2012
11. Marrinucci D, Bethel K, Kolatkar A, Luttgen MS, Malchiodi M, Baehring F, Voigt K, Lazar D, Nieva J, Bazhenova L, Ko AH, Korn WM, Schram E, Coward M, Yang X, Metzner T, Lamy R, Honnatti M, Yoshioka C, Kunken J, Petrova Y, Sok D, Nelson D, Kuhn P. Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers. Phys Biol 9: 016003, 2012
12. McCarty OJ, Mousa SA, Bray PF, Konstantopoulos K. Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions. Blood 96: 1789–1797, 2000
13. Mueller BM, Ruf W. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest 101: 1372–1378, 1998
14. Nieva J, Wendel M, Luttgen MS, Marrinucci D, Bazhenova L, Kolatkar A, Santala R, Whittenberger B, Burke J, Torrey M, Bethel K, Kuhn P. High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis. Phys Biol 9: 016004, 2012
15. Pedley TJ. The Fluid Mechanics of Large Blood Vessels. New York: Cambridge Univ. Press, 1980, p. 15, 446 p.
16. Phillips KG, Baker-Groberg SM, McCarty OJ. Quantitative optical microscopy: measurement of cellular biophysical features with a standard optical microscope. J Vis Exp 86: 2014; doi: 10.3791/50988
17. Phillips KG, Kolatkar A, Rees KJ, Rigg R, Marrinucci D, Luttgen M, Bethel K, Kuhn P, McCarty OJ. Quantification of cellular volume and sub-cellular density fluctuations: comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient. Front Oncol 2: 96, 2012
18. Phillips KG, Kuhn P, McCarty OJ. Physical Biology in Cancer. 2. The physical biology of circulating tumor cells. Am J Physiol Cell Physiol 306: C80–C88, 2014
19. Phillips KG, Velasco CR, Li J, Kolatkar A, Luttgen M, Bethel K, Duggan B, Kuhn P, McCarty OJ. Optical quantification of cellular mass, volume, and density of circulating tumor cells identified in an ovarian cancer patient. Front Oncol 2: 72, 2012
20. Physical Sciences-Oncology Centers N, Agus DB, Alexander JF, Arap W, Ashili S, Aslan JE, Austin RH, Backman V, Bethel KJ, Bonneau R, Chen WC, Chen-Tanyolac C, Choi NC, Curley SA, Dallas M, Damania D, Davies PC, Decuzzi P, Dickinson L, Estevez-Salmeron L, Estrella V, Ferrari M, Fischbach C, Foo J, Fraley SI, Frantz C, Fuhrmann A, Gascard P, Gatenby RA, Geng Y, Gerecht S, Gillies RJ, Godin B, Grady WM, Greenfield A, Hemphill C, Hempstead BL, Hielscher A, Hillis WD, Holland EC, Ibrahim-Hashim A, Jacks T, Johnson RH, Joo A, Katz JE, Kelbauskas L, Kesselman C, King MR, Konstantopoulos K, Kraning-Rush CM, Kuhn P, Kung K, Kwee B, Lakins JN, Lambert G, Liao D, Licht JD, Liphardt JT, Liu L, Lloyd MC, Lyubimova A, Mallick P, Marko J, McCarty OJ, Meldrum DR, Michor F, Mumenthaler SM, Nandakumar V, O’Halloran TV, Oh S, Pasqualini R, Paszek MJ, Philips KG, Poultney CS, Rana K, Reinhart-King CA, Ros R, Semenza GL, Senechal P, Shuler ML, Srinivasan S, Staunton JR, Stypula Y, Subramanian H, Tlsty TD, Tormoen GW, Tseng Y, van Oudenaarden A, Verbridge SS, Wan JC, Weaver VM, Widom J, Will C, Wirtz D, Wojtkowiak J, Wu PH. A physical sciences network characterization of nontumorigenic and metastatic cells. Sci Rep 3: 1449, 2013
21. Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 338: 1169–1173, 1998
22. Tormoen GW, Haley KM, Levine RL, McCarty OJ. Do circulating tumor cells play a role in coagulation and thrombosis? Front Oncol 2: 115, 2012
23. Tormoen GW, Recht O, Gruber A, Levine RL, McCarty OJ. Phosphatidylserine index as a marker of the procoagulant phenotype of acute myelogenous leukemia cells. Phys Biol 10: 056010, 2013
24. Tormoen GW, Rugonyi S, Gruber A, McCarty OJ. The role of carrier number on the procoagulant activity of tissue factor in blood and plasma. Phys Biol 8: 066005, 2011
25. van Herk-Sukel MP, Shantakumar S, Penning-van Beest FJ, Kamphuisen PW, Majoor CJ, Overbeek LI, Herings RM. Pulmonary embolism, myocardial infarction, and ischemic stroke in lung cancer patients: results from a longitudinal study. Lung 191: 501–509, 2013
26. Welsh J, Smith JD, Yates KR, Greenman J, Maraveyas A, Madden LA. Tissue factor expression determines tumour cell coagulation kinetics. Int J Lab Hematol 34: 396–402, 2012.